{"id":71466,"date":"2026-05-20T12:20:00","date_gmt":"2026-05-20T12:20:00","guid":{"rendered":"https:\/\/medsbase.com\/b12-cyanocobalamin\/"},"modified":"2026-10-15T10:33:56","modified_gmt":"2026-10-15T10:33:56","slug":"b12-cyanocobalamin","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-br\/product\/b12-cyanocobalamin\/","title":{"rendered":"Vitamin B12 (Cyanocobalamin) Injectable \u2014 Pharmaceutical Grade"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Resposta R\u00e1pida \u2014 O que \u00e9 B12 (Cianocobalamina) Injet\u00e1vel?<\/h3>\n<p style=\"margin: 0;\"><strong>Vitamina B12 (Cianocobalamina)<\/strong> \u00e9 a forma sint\u00e9tica ciano-coordenada da fam\u00edlia da coenzima cobalamina (CAS 68-19-9, MF C<sub>63<\/sub>H<sub>88<\/sub>CoN<sub>14<\/sub>O<sub>14<\/sub>P, MW 1355,37 g\/mol). Fornecido aqui como um <strong>frasco injet\u00e1vel multidose de 10 mg por 10 mL<\/strong> (1 mg\/mL pre-formulated sterile aqueous solution \u2014 no reconstitution required) for studies and companion-protocol use alongside the peptide catalogue. Cyanocobalamin is the most-cited B12 form in published studies because it is the most chemically stable: cells take it up via the transcobalamin-II \/ cubilin pathway and convert it intracellularly to the two biologically-active cobalamin forms \u2014 <strong>metilcobalamina<\/strong> (cofator para metionina sintase \/ ciclo SAM \/ metabolismo de um carbono) e <strong>adenosilcobalamina<\/strong> (cofactor for methylmalonyl-CoA mutase \/ odd-chain fatty acid metabolism \/ TCA entry). For clinical studies use only. <em>N\u00e3o \u00e9 um pept\u00eddeo<\/em> \u2014 pequena mol\u00e9cula corrinoide centrada em cobalto.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que voc\u00ea obt\u00e9m com a MedsBase:<\/strong> Pre-formulated sterile aqueous solution \u00b7 \u226599% HPLC-verified cyanocobalamin \u00b7 COA available on request \u00b7 Discreet temperature-controlled packaging \u00b7 Worldwide peptide courier \u00b7 1,400+ verified <a href=\"https:\/\/medsbase.com\/pt-br\/reviews\/\">\ud83d\udce6 Cada pedido \u00e9 coberto pela nossa<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Todo pedido \u00e9 coberto pelo nosso <a href=\"https:\/\/medsbase.com\/pt-br\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Reenvio Garantido<\/strong><\/a> \u2014 se sua encomenda n\u00e3o chegar em 20 dias \u00fateis, n\u00f3s a reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especifica\u00e7\u00e3o<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalhe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Classe do Composto<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Coenzima corrinoide centrada em cobalto; fam\u00edlia da vitamina B12; cofator de pequena mol\u00e9cula; <em>n\u00e3o \u00e9 um pept\u00eddeo<\/em><\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Nome Qu\u00edmico<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Cianocobalamina (sin\u00f4nimos: Vitamina B12, cobalamina (forma ciano), CN-B12; a forma sint\u00e9tica estabilizada com coordena\u00e7\u00e3o ciano da fam\u00edlia da cobalamina)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">68-19-9 (cianocobalamina); CAS relacionados \u00e0 cobalamina \u2014 metilcobalamina 13422-55-4, hidroxocobalamina 13422-51-0, adenosilcobalamina 13870-90-1 (n\u00e3o fornecido aqui)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>63<\/sub>H<sub>88<\/sub>CoN<sub>14<\/sub>O<sub>14<\/sub>P<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1355.37 g\/mol<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Mecanismo<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">A cianocobalamina entra nas c\u00e9lulas via via receptor-mediada transcobalamina-II \u2192 cubilina e \u00e9 convertida intracelularmente pela metionina sintase redutase (MTRR) e pela prote\u00edna do tipo acid\u00faria metilmal\u00f4nica cblA (MMAA) nos dois coenzimas cobalaminas biologicamente ativas \u2014 <strong>metilcobalamina<\/strong> (cofator citos\u00f3lico para a metionina sintase) e <strong>adenosilcobalamina<\/strong> (cofator mitocondrial para a metilmalonil-CoA mutase). Ambos os coenzimas s\u00e3o essenciais para o metabolismo do carbono um \/ metila\u00e7\u00e3o e do propionil-CoA \/ \u00e1cidos graxos de cadeia \u00edmpar, respectivamente.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequ\u00eancia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">n\/a (coenzima corrinoide de pequena mol\u00e9cula \u2014 n\u00e3o um pept\u00eddeo)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma &amp; Concentra\u00e7\u00e3o<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Solu\u00e7\u00e3o aquosa est\u00e9ril pr\u00e9-formulada<\/strong> \u2014 1 mg\/mL cyanocobalamin in physiological-buffer base, 10 mL multi-dose vial (10 mg total cyanocobalamin per vial). Characteristic deep red colour from the cobalt-corrin chromophore. <strong>Nenhuma reconstitui\u00e7\u00e3o necess\u00e1ria<\/strong> \u2014 aspirar assepticamente com seringa est\u00e9ril.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC); padr\u00e3o de refer\u00eancia de cianocobalamina grau USP. COA dispon\u00edvel mediante solicita\u00e7\u00e3o.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidade<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Altamente sol\u00favel em \u00e1gua (~12,5 mg\/mL de limite de solubilidade a 25 \u00b0C); solu\u00e7\u00e3o pr\u00e9-formulada est\u00e1 bem abaixo da satura\u00e7\u00e3o. Est\u00e1vel em tamp\u00e3o aquoso com pH 4\u20137. Evitar condi\u00e7\u00f5es alcalinas (forma\u00e7\u00e3o r\u00e1pida de hidroxocobalamina) e condi\u00e7\u00f5es fortemente redutoras (gera\u00e7\u00e3o de cob(II)alamina).<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Armazenamento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Manter refrigerado a 2\u20138 \u00b0C; <strong>proteger da luz<\/strong> (a cianocobalamina \u00e9 fotossens\u00edvel \u2014 luz UV\/azul catalisa a convers\u00e3o de ciano para hidroxi). Usar o frasco multidose dentro de 60 dias ap\u00f3s a primeira pun\u00e7\u00e3o. N\u00e3o congelar (a forma\u00e7\u00e3o de cristais de gelo pode rachar o frasco de vidro e h\u00e1 risco de degrada\u00e7\u00e3o fotol\u00edtica durante armazenamento prolongado congelado). Usar dentro do prazo de validade indicado no r\u00f3tulo do frasco (geralmente 24 meses a partir da fabrica\u00e7\u00e3o).<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>O Que \u00c9 Vitamina B12 (Cianocobalamina)?<\/h2>\n<p><strong>Cianocobalamina<\/strong> (CAS 68-19-9) \u00e9 a forma sint\u00e9tica, coordenada por ciano, da fam\u00edlia de coenzimas cobalamina da vitamina B12. Estruturalmente, \u00e9 um corrinoide complexo centrado em cobalto: um anel macroc\u00edclico de 19 \u00e1tomos (o anel corrina, semelhante em geometria ao anel porfirina da hemoglobina, mas distinto em composi\u00e7\u00e3o) coordena um \u00edon de cobalto central em seu estado de oxida\u00e7\u00e3o 3+, com uma cauda de nucleot\u00eddeo dimetilbenzimidazol pendurada abaixo do anel e um grupo ciano (-CN) ocupando a posi\u00e7\u00e3o axial superior. F\u00f3rmula molecular C<sub>63<\/sub>H<sub>88<\/sub>CoN<sub>14<\/sub>O<sub>14<\/sub>P, molecular weight 1355.37 g\/mol. The molecule is intensely red \u2014 its visible-spectrum absorption (\u03bbmax ~360, ~520, ~550 nm) is what gives B12 solutions their characteristic deep pink-red colour. The &#8220;cyano&#8221; form is a synthetic stabilisation choice rather than a biologically-significant species in vivo. Cobalamins in cells exist primarily as <strong>metilcobalamina<\/strong> (um grupo metil na posi\u00e7\u00e3o axial superior \u2014 o cofator citos\u00f3lico para a metionina sintase) e <strong>adenosilcobalamina<\/strong> (a 5\u2032-deoxyadenosyl group on the upper axial position \u2014 the mitochondrial cofactor for methylmalonyl-CoA mutase). These two active forms are interconverted by dedicated cellular enzymes and are not commercially supplied in stable injectable form because of their light-sensitivity. Cyanocobalamin is supplied instead because the cyano group is photochemically and thermally stable, and cells convert cyanocobalamin to the methyl and adenosyl forms intracellularly via methionine synthase reductase (MTRR) and the methylmalonic aciduria cblA-type protein (MMAA), respectively. In the studies and clinical context, cyanocobalamin injectable preparations are the canonical supplemental form. The 10 mL multi-dose vial format (1 mg\/mL \u00d7 10 mL = 10 mg per vial) supplied here matches the standard pharmaceutical preparation pattern. MedsBase stocks this format in the peptide-studies catalogue as a small-molecule companion compound used in protocols that combine peptide studies with cobalamin-axis biology \u2014 recovery, methylation-cycle studies, hematology, cognitive studies with nootropic peptides, and energy-metabolism panels where the SAM cycle is engaged. <\/p>\n<h2>Mecanismo de A\u00e7\u00e3o \u2014 Duas Rea\u00e7\u00f5es de Cobalamina-Coenzima<\/h2>\n<p>O mecanismo biol\u00f3gico da B12 \/ cianocobalamina \u00e9 a soma das duas rea\u00e7\u00f5es enzim\u00e1ticas catalisadas pelas coenzimas de cobalamina ativas derivadas dela:<\/p>\n<ul>\n<li><strong>Capta\u00e7\u00e3o celular via transcobalamina-II \u2192 cubilina \/ megalina<\/strong> \u2014 A cianocobalamina livre no fluido extracelular \u00e9 ligada pela transcobalamina-II (TCII), e o complexo TCII-B12 \u00e9 captado pelo sistema receptor cubilina \/ megalina nas superf\u00edcies celulares. A libera\u00e7\u00e3o intracelular no lisossomo \u00e9 seguida pelo transporte para o citosol via o complexo de efluxo LMBRD1 \/ ABCD4.<\/li>\n<li><strong>Convers\u00e3o intracelular em coenzimas ativas<\/strong> \u2014 No citosol, a metionina sintase redutase (MTRR) reduz e metila a cianocobalamina para <strong>metilcobalamina<\/strong> (a forma citos\u00f3lica ativa), perdendo o grupo ciano como cianeto (que \u00e9 ent\u00e3o desintoxicado pelo sistema rodanase \/ tiossulfato nas quantidades muito baixas geradas). Na mitoc\u00f4ndria, a prote\u00edna do tipo cblA da acid\u00faria metilmal\u00f4nica (MMAA) mais a metionina sintase redutase converte a cianocobalamina em <strong>adenosilcobalamina<\/strong> (a forma mitocondrial ativa).<\/li>\n<li><strong>Metilcobalamina \u2192 metionina sintase (citos\u00f3lica, ciclo de um carbono \/ SAM)<\/strong> \u2014 A metionina sintase catalisa a transfer\u00eancia de um grupo metil do 5-metil-tetrahidrofolato para a homociste\u00edna, regenerando metionina e tetrahidrofolato. Este \u00e9 o elo cr\u00edtico entre B12, folato e o ciclo da metionina \/ SAM. SAM (S-adenosil-metionina, gerada a partir de metionina + ATP) \u00e9 o doador universal de metil celular para as centenas de rea\u00e7\u00f5es de metila\u00e7\u00e3o celular \u2014 metila\u00e7\u00e3o de DNA, metila\u00e7\u00e3o de histonas, metila\u00e7\u00e3o de fosfolip\u00eddios, metila\u00e7\u00e3o de neurotransmissores (catecolaminas, melatonina), bioss\u00edntese de creatina. A defici\u00eancia de B12, portanto, perturba todo o programa de metila\u00e7\u00e3o da c\u00e9lula e \u00e9 a base molecular para as sequelas hematol\u00f3gicas (anemia megalobl\u00e1stica por s\u00edntese de timidina prejudicada dependente de metila\u00e7\u00e3o de DNA) e neurol\u00f3gicas (desmieliniza\u00e7\u00e3o por metila\u00e7\u00e3o de fosfolip\u00eddios prejudicada) da defici\u00eancia cl\u00ednica de B12.<\/li>\n<li><strong>Adenosilcobalamina \u2192 metilmalonil-CoA mutase (mitocondrial, entrada de propionil-CoA \/ TCA)<\/strong> \u2014 A metilmalonil-CoA mutase catalisa o rearranjo intramolecular de (R)-metilmalonil-CoA para succinil-CoA. Este \u00e9 o ponto de entrada metab\u00f3lica para substratos geradores de propionil-CoA \u2014 \u00e1cidos graxos de cadeia \u00edmpar, amino\u00e1cidos de cadeia ramificada (valina, isoleucina, metionina), cadeia lateral do colesterol. A defici\u00eancia de adenosilcobalamina causa ac\u00famulo de metilmalonato (o biomarcador diagn\u00f3stico da defici\u00eancia cl\u00ednica de B12) e prejudica a oxida\u00e7\u00e3o de propionil-CoA \/ \u00e1cidos graxos de cadeia \u00edmpar.<\/li>\n<li><strong>Conex\u00e3o entre o eixo NAD e o crossover do metabolismo de um carbono<\/strong> \u2014 A rea\u00e7\u00e3o de B12 \/ metionina-sintase est\u00e1 no mesmo n\u00f3 metab\u00f3lico que as rea\u00e7\u00f5es de metila\u00e7\u00e3o que consomem SAM, catalisadas por centenas de metiltransferases celulares, incluindo NNMT (nicotinamida N-metiltransferase) \u2014 o alvo de <a href=\"https:\/\/medsbase.com\/pt-br\/5-amino-1mq\/\">5-Amino-1MQ<\/a>. NNMT consumes SAM to methylate nicotinamide; impaired B12 \/ methionine-synthase function lowers cellular SAM availability and therefore lowers NNMT activity indirectly. Studies that probes the NAD-axis \/ one-carbon-metabolism crossover often co-administers B12 and NNMT-pathway tools to dissect these connected biochemistries.<\/li>\n<\/ul>\n<p>The pharmacokinetic profile of injectable cyanocobalamin is well-characterised: IM or SC administration produces rapid systemic absorption with peak plasma concentrations at 1\u20132 hours; substantial dose-dependent renal clearance (the kidney saturates and dose-dumps any cyanocobalamin above the transcobalamin-II carrier capacity); cellular uptake then proceeds over hours-to-days; conversion to active coenzymes happens continuously thereafter; and the very low daily turnover requirement of cobalamin coenzymes (~2 \u00b5g\/d in human physiology) means that single high-dose injections produce sustained tissue-level effects for weeks. The 1 mg\/mL \u00d7 10 mL multi-dose format supports typical protocols ranging from single-bolus high-dose work to weekly or daily smaller-dose chronic dosing. <\/p>\n<h2>Published Evidence<\/h2>\n<p>B12 \/ cyanocobalamin is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>One-carbon metabolism and SAM-cycle studies<\/strong> \u2014 the canonical small-molecule cofactor for methionine synthase; standard tool compound for any studies that probes the folate \/ B12 \/ methionine \/ SAM axis; widely used in DNA-methylation and histone-methylation pharmacology studies<\/li>\n<li><strong>Homocysteine-axis studies<\/strong> \u2014 methionine synthase deficiency \/ impairment causes homocysteine accumulation; cyanocobalamin supplementation is the standard intervention in published studies models of hyperhomocysteinaemia and cardiovascular risk<\/li>\n<li><strong>Haematology and erythropoiesis studies<\/strong> \u2014 B12 deficiency causes megaloblastic anaemia via impaired DNA-methylation-dependent thymidine synthesis; published studies uses cyanocobalamin in vitamin-deficiency erythropoiesis models, bone-marrow culture studies, and reticulocyte-response studies<\/li>\n<li><strong>Peripheral neuropathy and demyelination studies<\/strong> \u2014 B12 deficiency causes peripheral neuropathy and subacute combined degeneration of the spinal cord via impaired phospholipid methylation in myelin sheaths; published studies uses cyanocobalamin supplementation in demyelination \/ remyelination model systems<\/li>\n<li><strong>NAD-axis \/ methylation crossover studies<\/strong> \u2014 combinado com <a href=\"https:\/\/medsbase.com\/pt-br\/5-amino-1mq\/\">5-Amino-1MQ<\/a> (inibidor de NNMT) ou <a href=\"https:\/\/medsbase.com\/pt-br\/nad\/\">NAD\u207a<\/a> in published studies that probes the SAM-cycle \/ nicotinamide-methylation node<\/li>\n<li><strong>Recovery and athletic-applications (combined with peptide protocols)<\/strong> \u2014 frequently included as a companion compound in protocols that combine peptide therapeutics (BPC-157, TB-500, GH peptides) with cofactor \/ vitamin support; the canonical small-molecule companion to peptide-axis recovery<\/li>\n<li><strong>Cognitive and nootropic-applications<\/strong> \u2014 combinado com pept\u00eddeos cognitivos (<a href=\"https:\/\/medsbase.com\/pt-br\/selank\/\">Selank<\/a>, <a href=\"https:\/\/medsbase.com\/pt-br\/semax\/\">Semax<\/a>, <a href=\"https:\/\/medsbase.com\/pt-br\/dsip\/\">DSIP<\/a>) in studies on the cognitive sequelae of B12 deficiency and the cobalamin axis in CNS function<\/li>\n<li><strong>Cyanocobalamin vs methylcobalamin vs hydroxocobalamin comparative studies<\/strong> \u2014 published studies has compared the four cobalamin forms head-to-head for bioavailability, intracellular conversion kinetics, and tissue-retention profiles; cyanocobalamin is the canonical reference compound against which the others are benchmarked<\/li>\n<\/ul>\n<p>For broader context on small-molecule cofactor \/ coenzyme compounds in this catalogue, see <a href=\"https:\/\/medsbase.com\/pt-br\/l-carnitine\/\">L-Carnitina<\/a> (the closest small-molecule companion analogue \u2014 mitochondrial long-chain fatty-acid shuttle), <a href=\"https:\/\/medsbase.com\/pt-br\/nad\/\">NAD\u207a<\/a> (coenzima dinucleot\u00eddica oxidada \u2014 suplementa\u00e7\u00e3o direta do pool de NAD), <a href=\"https:\/\/medsbase.com\/pt-br\/5-amino-1mq\/\">5-Amino-1MQ<\/a> (inibidor de NNMT \u2014 conecta o ciclo de B12\/metionina ao eixo NAD), e <a href=\"https:\/\/medsbase.com\/pt-br\/mots-c\/\">MOTS-c<\/a> (pept\u00eddeo metab\u00f3lico derivado mitocondrial). Navegue pelo <a href=\"https:\/\/medsbase.com\/pt-br\/peptides\/\">peptides &amp; compounds catalog<\/a>. <\/p>\n<h2>Tamanhos de Embalagem Dispon\u00edveis<\/h2>\n<p>A MedsBase oferece Vitamina B12 (Cianocobalamina) Injet\u00e1vel em uma \u00fanica concentra\u00e7\u00e3o\/formato de frasco com tr\u00eas op\u00e7\u00f5es de tamanho de embalagem:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tamanho do pacote<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de Uso T\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Material Total<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>1 Frasco<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Single-experiment, dose-titration, or short-course in-vivo studies \u2014 10 mg total cyanocobalamin in 10 mL multi-dose format covers 4\u20138 weeks of typical protocol dosing in rodents or small-cohort cell-culture work<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 mg \/ 10 mL<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 Frascos<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Multi-cohort or extended-cycle studies \u2014 typical mid-scale protocols using B12 as a companion compound alongside peptide-dosing; per-vial economics improve significantly vs single-vial purchase<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">50 mg \/ 50 mL<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 Frascos<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Large-cohort or long-arm protocols \u2014 chronic-dosing companion supply alongside long-cycle peptide protocols; lowest per-mg cost; covers multi-animal cohort work without re-purchase<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100 mg \/ 100 mL<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The single 1-vial pack is convenient for single-experiment or titration work; the 5-vial and 10-vial packs provide significant per-vial savings for chronic protocols or multi-cohort studies. The 1 mg\/mL \u00d7 10 mL multi-dose format matches the standard pharmaceutical injectable cyanocobalamin pattern and is well-suited to typical protocol dosing \u2014 IM, SC, or IV administration of 100 \u00b5g to 1 mg per dose (equivalent to 0.1\u20131 mL of the supplied solution) covers essentially all published studies dose ranges. <\/p>\n<h2>Como Comparar \u2014 B12 (Cianocobalamina) vs L-Carnitina<\/h2>\n<p>B12 e <a href=\"https:\/\/medsbase.com\/pt-br\/l-carnitine\/\">L-Carnitina<\/a> are the two best-characterised small-molecule companion compounds in this catalogue. Both serve as cofactor \/ shuttle compounds in mitochondrial and metabolic support, both are supplied in multi-dose injectable formats appropriate for protocol use alongside the peptide catalogue, and both are mechanistically distinct from the peptide compounds. The comparison illustrates the two canonical &#8220;small-molecule companion&#8221; compounds that users add to peptide protocols. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e9rio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">B12 (Cianocobalamina)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">L-Carnitina<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Classe qu\u00edmica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Corrinoide coenzim\u00e1tico centrado em cobalto (mol\u00e9cula pequena \u00fanica)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Derivado de amino\u00e1cido quatern\u00e1rio de am\u00f4nio (zwitterion \u00fanico)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1355.37 g\/mol<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">161.20 g\/mol<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Papel celular<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Cofator \u2014 metionina sintase (citoss\u00f3lico, ciclo SAM) + metilmalonil-CoA mutase (mitocondrial, propionil-CoA \u2192 TCA)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Transportador de substrato \u2014 transporte de \u00e1cidos graxos de cadeia longa atrav\u00e9s da membrana mitocondrial interna (entrada na \u03b2-oxida\u00e7\u00e3o)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Best studies focus<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">One-carbon \/ methylation, homocysteine axis, megaloblastic erythropoiesis, demyelination studies, cognitive \/ nootropic crossover<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fat oxidation, mitochondrial bioenergetics, insulin sensitivity, sperm motility, cardiovascular metabolic support<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Aprova\u00e7\u00e3o da FDA<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sim \u2014 cianocobalamina injet\u00e1vel aprovada para defici\u00eancia de vitamina B12; hidroxocobalamina aprovada como Cyanokit (ant\u00eddoto para cianeto)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sim \u2014 levocarnitina aprovada para defici\u00eancia prim\u00e1ria\/secund\u00e1ria de carnitina (oral e IV)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Requerimento di\u00e1rio de renova\u00e7\u00e3o<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Muito baixo (~2 \u00b5g\/d na fisiologia humana) \u2014 inje\u00e7\u00f5es \u00fanicas de alta dose mant\u00eam n\u00edveis teciduais por semanas<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Alto \u2014 pool end\u00f3geno de carnitina ~25 g; a necessidade di\u00e1ria de reposi\u00e7\u00e3o em estados de defici\u00eancia \u00e9 substancial<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Forma fornecida<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Solu\u00e7\u00e3o aquosa est\u00e9ril pr\u00e9-formulada (1 mg\/mL \u00d7 10 mL multidose<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">P\u00f3 liofilizado (reconstituir com \u00e1gua BAC)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dose t\u00edpica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">100 \u00b5g a 1 mg por dose (0,1\u20131 mL da solu\u00e7\u00e3o fornecida), IM \/ SC \/ IV<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Centenas de mg a n\u00edvel de grama por dose (protocolos em roedores \/ animais grandes)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For studies focused on one-carbon metabolism, SAM cycle, homocysteine axis, or megaloblastic erythropoiesis, B12 \/ cyanocobalamin is the canonical small-molecule companion. For studies focused on long-chain fatty-acid oxidation, mitochondrial bioenergetics, or insulin sensitivity, <a href=\"https:\/\/medsbase.com\/pt-br\/l-carnitine\/\">L-Carnitina<\/a> is the more targeted tool. The two compounds are commonly co-administered as part of broader peptide-protocols that benefit from both methylation-cycle and fatty-acid-oxidation cofactor support. <\/p>\n<h2>Armazenamento e Manuseio<\/h2>\n<p><strong>Solu\u00e7\u00e3o pr\u00e9-formulada \u2014 n\u00e3o requer reconstitui\u00e7\u00e3o.<\/strong> Ao contr\u00e1rio dos produtos pept\u00eddicos liofilizados neste cat\u00e1logo, a cianocobalamina injet\u00e1vel \u00e9 fornecida como uma solu\u00e7\u00e3o aquosa est\u00e9ril pronta para uso. Retire assepticamente com uma seringa est\u00e9ril a cada uso; n\u00e3o introduza contaminantes no frasco multidose. <strong>Armazenamento:<\/strong> Armazenar refrigerado a 2\u20138 \u00b0C na embalagem original. <strong>Proteger da luz em todos os momentos<\/strong> \u2014 cyanocobalamin is photosensitive (UV and short-wavelength visible light catalyses cyano-to-hydroxo and cyano-to-cob(II)alamin photoproducts). Store the vial in its original light-protective box or wrap in foil if removed. Avoid prolonged exposure to clinical ambient light during handling. <strong>N\u00e3o congelar.<\/strong> A forma\u00e7\u00e3o de cristais de gelo pode rachar o frasco de vidro, e o armazenamento congelado n\u00e3o oferece benef\u00edcio de estabilidade al\u00e9m da refrigera\u00e7\u00e3o para uma solu\u00e7\u00e3o aquosa j\u00e1 formulada. A solu\u00e7\u00e3o \u00e9 est\u00e1vel a 2\u20138 \u00b0C por pelo menos 24 meses a partir da data de fabrica\u00e7\u00e3o em estado n\u00e3o aberto. <strong>Ap\u00f3s a primeira pun\u00e7\u00e3o:<\/strong> use o frasco multidose dentro de 60 dias. O tamp\u00e3o pr\u00e9-formulado inclui conservantes (geralmente \u00e1lcool benz\u00edlico ou fenol em concentra\u00e7\u00f5es farmac\u00eauticas) que mant\u00eam a esterilidade durante o uso multidose, mas pun\u00e7\u00f5es cumulativas no septo eventualmente podem permitir a entrada de microrganismos. Descartar se houver turva\u00e7\u00e3o, part\u00edculas, mudan\u00e7a acentuada de cor (especialmente desbotamento do vermelho intenso caracter\u00edstico \u2014 indica fotodegrada\u00e7\u00e3o) ou precipita\u00e7\u00e3o. <\/p>\n<h2>Perguntas Frequentes<\/h2>\n<h3>Por que a solu\u00e7\u00e3o de B12 fornecida tem uma cor vermelha intensa?<\/h3>\n<p>O anel corrina centrado em cobalto das cobalaminas \u00e9 um forte crom\u00f3foro no espectro vis\u00edvel \u2014 as bandas de absor\u00e7\u00e3o \u03bbmax da cianocobalamina em ~360 nm (UV), ~520 nm (verde) e ~550 nm (verde-amarelo) produzem a cor transmitida caracter\u00edstica vermelho-rosa. Qualquer solu\u00e7\u00e3o de cianocobalamina deve parecer intensamente vermelha; o desbotamento para amarelo ou marrom indica fotodegrada\u00e7\u00e3o (convers\u00e3o de ciano para hidroxi ou redu\u00e7\u00e3o adicional para cob(II)alamina) e o frasco deve ser descartado. <\/p>\n<h3>Por que este produto de B12 usa a forma ciano em vez de metil- ou hidroxicobalamina?<\/h3>\n<p>Cyanocobalamin is the standard form supplied as injectable B12 because it is photochemically and thermally the most stable of the cobalamin forms \u2014 the cyano group resists the photolytic degradation that affects methyl-, hydroxo-, and adenosylcobalamin in solution. Once cyanocobalamin enters cells, intracellular enzymes (MTRR, MMAA) convert it to the biologically-active methylcobalamin and adenosylcobalamin forms. For most applications, cyanocobalamin is therefore the practical choice. Users specifically studying methylcobalamin or hydroxocobalamin pharmacology (e.g., differential cellular-uptake kinetics, light-degradation pathways, or cyanide-antidote applications) require those specific forms separately. <\/p>\n<h3>Este produto de B12 \u00e9 um pept\u00eddeo?<\/h3>\n<p>N\u00e3o. A cianocobalamina \u00e9 uma pequena mol\u00e9cula de coenzima corrinoide centrada em cobalto (MW 1355,37 g\/mol), <em>n\u00e3o<\/em> a peptide. We stock it in our peptide-studies catalogue as the canonical small-molecule companion compound used in protocols that combine peptide studies with cobalamin-axis biology. The spec table Sequence row is marked &#8220;n\/a&#8221; for this reason. Other small-molecule companions in this catalogue include <a href=\"https:\/\/medsbase.com\/pt-br\/l-carnitine\/\">L-Carnitina<\/a>, <a href=\"https:\/\/medsbase.com\/pt-br\/nad\/\">NAD\u207a<\/a>, <a href=\"https:\/\/medsbase.com\/pt-br\/5-amino-1mq\/\">5-Amino-1MQ<\/a>, e <a href=\"https:\/\/medsbase.com\/pt-br\/aicar-acadesine\/\">AICAR<\/a>. <\/p>\n<h3>What published dose ranges have been used in studies?<\/h3>\n<p>Injectable cyanocobalamin published dosing in human-clinical and rodent in-vivo work typically uses 100\u20131000 \u00b5g per dose (0.1\u20131.0 mL of the supplied 1 mg\/mL solution), IM or SC, daily for the first week and then weekly or monthly thereafter for chronic protocols. The 1000 \u00b5g single bolus is the canonical &#8220;loading dose&#8221; in clinical-translational studies. In-vitro cell-culture protocols typically use nanomolar to micromolar concentrations. Users should consult primary literature appropriate to the specific application (haematology, neuropathy, cardiovascular, one-carbon metabolism, etc.). <\/p>\n<h3>Can B12 be combined with peptides like Selank, Semax, or DSIP in protocols?<\/h3>\n<p>Sim \u2014 a B12 \u00e9 comumente combinada com pept\u00eddeos nootr\u00f3picos (<a href=\"https:\/\/medsbase.com\/pt-br\/selank\/\">Selank<\/a>, <a href=\"https:\/\/medsbase.com\/pt-br\/semax\/\">Semax<\/a>, <a href=\"https:\/\/medsbase.com\/pt-br\/dsip\/\">DSIP<\/a>) in studies on the cognitive sequelae of cobalamin deficiency and the broader cobalamin-axis contribution to CNS function. B12 is also commonly co-administered with recovery peptides (BPC-157, TB-500), growth-hormone peptides (<a href=\"https:\/\/medsbase.com\/pt-br\/sermorelin\/\">Sermorelina<\/a>, <a href=\"https:\/\/medsbase.com\/pt-br\/tesamorelin\/\">Tesamorelina<\/a>) e pept\u00eddeos metab\u00f3licos (<a href=\"https:\/\/medsbase.com\/pt-br\/mots-c\/\">MOTS-c<\/a>) como cofator companheiro. A forma aquosa pr\u00e9-formulada significa que pode ser aspirada fresca em uma seringa separada para cada administra\u00e7\u00e3o \u2014 n\u00e3o misture com outras solu\u00e7\u00f5es de pept\u00eddeos na mesma seringa, pois o crom\u00f3foro de corrina-cobalto pode interagir com pept\u00eddeos contendo tiol e induzir efeitos fotoredox menores. <\/p>\n<h3>Por que a cianocobalamina \u00e0s vezes \u00e9 mencionada junto com cianeto?<\/h3>\n<p>The cyano group on cyanocobalamin is a very small amount of bound cyanide \u2014 when intracellular enzymes convert cyanocobalamin to the active methyl\/adenosyl forms, free cyanide is released in stoichiometric amount, but the quantity is very small (~25 \u00b5g of cyanide per 1 mg of cyanocobalamin) and is detoxified by the cellular rhodanese \/ thiosulfate system without clinical significance. The opposite reaction \u2014 cobalamin scavenging cyanide \u2014 is the basis of hydroxocobalamin&#8217;s approved use as a cyanide-antidote drug (Cyanokit), where high-dose hydroxocobalamin sequesters circulating cyanide as cyanocobalamin for renal excretion. Users in cyanide-antidote studies require hydroxocobalamin specifically, not cyanocobalamin. <\/p>\n<h3>How does this pharmaceutical-grade B12 compare with the existing branded B12 products on MedsBase?<\/h3>\n<p>Os produtos de B12 j\u00e1 existentes na MedsBase (por exemplo, <a href=\"https:\/\/medsbase.com\/pt-br\/vitamin-b12\/\">Vitamina B12 1500 mcg Comprimidos<\/a>) are clinical-pharmaceutical-grade B12 packaged in tablet form for oral \/ sublingual use, positioned in the nerve-health \/ energy-supplement category. The pharmaceutical-grade B12 supplied here is the injectable cyanocobalamin form in 10 mL multi-dose vial format, positioned in the peptide-studies catalogue as a small-molecule companion alongside the peptide compounds. Users requiring an oral \/ sublingual B12 supplement should use the tablet products; users requiring injectable cyanocobalamin for in-vivo or cell-culture work alongside peptide protocols can use the material supplied here. <\/p>\n<h3>O B12 est\u00e1 na Lista de Proibidos da WADA?<\/h3>\n<p>N\u00e3o. A vitamina B12\/cianocobalamina n\u00e3o est\u00e1 na Lista de Proibidos da WADA. \u00c9 um composto vitam\u00ednico\/cofator comumente usado tanto clinicamente (para tratamento de defici\u00eancia de B12) quanto como um suplemento permitido em contextos atl\u00e9ticos. N\u00e3o h\u00e1 restri\u00e7\u00f5es regulat\u00f3rias de desempenho atl\u00e9tico sobre cianocobalamina ou outras formas de cobalamina. <\/p>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 20px 0 8px; border-radius: 4px; font-size: 14px;\"><strong>Why order compounds from MedsBase:<\/strong> Lyophilized HPLC \u226599% peptides &amp; compounds \u00b7 COA available on request \u00b7 Discreet protective packaging \u00b7 Worldwide courier \u00b7 <a href=\"https:\/\/medsbase.com\/pt-br\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance<\/a> em cada pedido \u00b7 1.400+ verificados <a href=\"https:\/\/medsbase.com\/pt-br\/reviews\/\">\ud83d\udce6 Cada pedido \u00e9 coberto pela nossa<\/a><\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Small-Molecule Companion Compounds<\/h2>\n<ul>\n<li><a href=\"\/pt-br\/l-carnitine\/\"><strong>L-Carnitina<\/strong><\/a> \u2014 Mitochondrial fatty-acid shuttle \u2014 closest small-molecule companion analogue<\/li>\n<li><a href=\"\/pt-br\/nad\/\"><strong>NAD\u207a<\/strong><\/a> \u2014 Oxidised dinucleotide coenzyme \u2014 direct NAD-pool supplementation studies<\/li>\n<li><a href=\"\/pt-br\/5-amino-1mq\/\"><strong>5-Amino-1MQ<\/strong><\/a> \u2014 Inibidor de NNMT \u2014 conecta o ciclo de B12\/metionina \u00e0 metila\u00e7\u00e3o do eixo NAD<\/li>\n<li><a href=\"\/pt-br\/aicar-acadesine\/\"><strong>AICAR<\/strong><\/a> \u2014 Canonical small-molecule AMPK activator \u2014 companion metabolic support compound<\/li>\n<li><a href=\"\/pt-br\/mots-c\/\"><strong>MOTS-c<\/strong><\/a> \u2014 Mitochondrial-derived metabolic peptide \u2014 alternative-mechanism cofactor studies<\/li>\n<li><a href=\"\/pt-br\/bac-water\/\"><strong>\u00c1gua BAC (\u00c1gua Bacteriost\u00e1tica)<\/strong><\/a> \u2014 Necess\u00e1rio para reconstituir qualquer frasco liofilizado \u2014 diluente est\u00e9ril, preservado com 0,9% de \u00e1lcool benz\u00edlico<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Corrinoide com centro de cobalto \u2014 fam\u00edlia da vitamina B12 (CAS 68-19-9)<br \/>\n\u2705 Solu\u00e7\u00e3o aquosa est\u00e9ril pr\u00e9-formulada (n\u00e3o requer reconstitui\u00e7\u00e3o)<br \/>\n\u2705 1 mg\/mL \u00d7 10 mL multi-dose vial (10 mg total cyanocobalamin)<br \/>\n\u2705 Cofator da metionina sintase celular + mutase metilmalonil-CoA<br \/>\n\u2705 Small-molecule companion compound (MW 1355.37, USP-grade)<\/p>\n<p><strong>Vitamina B12 (Cianocobalamina) Injet\u00e1vel<\/strong> cont\u00e9m 1 mg\/mL \u00d7 10 mL de solu\u00e7\u00e3o est\u00e9ril de cianocobalamina.<\/p>","protected":false},"featured_media":71536,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6511,6510,6512,6513,6515,6514,3862],"class_list":["post-71466","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-cobalamin","product_tag-cyanocobalamin","product_tag-methionine-synthase-cofactor","product_tag-methylation-research","product_tag-research-companion","product_tag-small-molecule-research-compound","product_tag-vitamin-b12","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product\/71466","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/comments?post=71466"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/media\/71536"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/media?parent=71466"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_brand?post=71466"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_cat?post=71466"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_tag?post=71466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}